Hearing: China’s Healthcare Sector, Drug Safety, and the U.S.-China Trade in Medical Products (WEBCAST)

Thursday, April 03, 2014

Hearing Co-Chairs: Chairman Dennis C. Shea and Vice-Chairman William Reinsch

8:30 – 8:45 am                   Co-chairs’ remarks: Chairman Dennis C. Shea and Vice-Chairman William Reinsch

8:45 – 9:30 am                     Administration Panel

• Dr. Christopher J. Hickey, Country Director, U.S. Food and Drug Administration, People's Republic of China (Testimony)

9:30 am –9:45 am:              Break

9:45 am – 11:15 am            Panel I: Policy Challenges in China’s Healthcare Sector

• Dr. Karen Eggleston, Faculty Director, Asia Health Policy Program, Stanford University, Stanford, CA (Testimony)
• Dr. Yanzhong Huang, Senior Fellow for Global Health Policy, Council on Foreign Relations, New York, NY (Testimony)
• Xiaoqing Lu Boynton, Director, Albright Stonebridge Group, Washington, DC (Testimony)

11:15 am –11:30 am           Break

11:30 am – 1:00 pm            Panel II: Market Access for U.S. Medical Goods and Services in China

• Benjamin Shobert, Managing Director, Rubicon Strategy Group, Seattle, WA; Senior Associate, National Bureau of Asian Research, Washington, DC (Testimony)
• Rod Hunter, Senior Vice President, International Affairs, PhRMA, Washington, DC       
• Ralph Ives, Executive Vice President, Global Strategy and Analysis, AdvaMed, Washington, DC (Testimony)

1:00 – 2:00 pm                     Lunch break

2:00 pm – 3:30 pm              Panel III: The Safety of Medical Product Imports from China into the United States

• Allan Coukell, Senior Director, Drugs and Medical Devices, The Pew Charitable Trusts, Washington, DC (Testimony)
• Charles Bell, Programs Director, Consumers Union, Yonkers, NY (Testimony)
• Dr. Ginger Zhe Jin, Professor of Economics, University of Maryland, College Park, MD (Testimony)
• Dr. Roger Bate, Visiting Fellow, American Enterprise Institute, Washington, DC (Written Testimony)

3:30 pm                                  Adjourn